Theo Rispens
Theo Rispens
Sanquin Research, University of Amsterdam
Verified email at sanquin.nl
Title
Cited by
Cited by
Year
IgG subclasses and allotypes: from structure to effector functions
G Vidarsson, G Dekkers, T Rispens
Frontiers in immunology 5, 520, 2014
13902014
Immunoglobulin G4: an odd antibody
RC Aalberse, SO Stapel, J Schuurman, T Rispens
Clinical & Experimental Allergy 39 (4), 469-477, 2009
7902009
Immunogenicity of anti-TNF biologic therapies for rheumatoid arthritis
PA Van Schouwenburg, T Rispens, GJ Wolbink
Nature Reviews Rheumatology 9 (3), 164, 2013
3892013
Loss of infliximab into feces is associated with lack of response to therapy in patients with severe ulcerative colitis
JF Brandse, GR van den Brink, ME Wildenberg, D van der Kleij, ...
Gastroenterology 149 (2), 350-355. e2, 2015
2992015
Detection of infliximab levels and anti‐infliximab antibodies: a comparison of three different assays
N Vande Casteele, DJ Buurman, MGG Sturkenboom, JH Kleibeuker, ...
Alimentary pharmacology & therapeutics 36 (8), 765-771, 2012
2052012
Adalimumab elicits a restricted anti-idiotypic antibody response in autoimmune patients resulting in functional neutralisation
PA van Schouwenburg, LA van de Stadt, RN de Jong, EEL van Buren, ...
Annals of the rheumatic diseases 72 (1), 104-109, 2013
1932013
Differential effect of drug interference in immunogenicity assays
MH Hart, H de Vrieze, D Wouters, GJ Wolbink, J Killestein, ER de Groot, ...
Journal of immunological methods 372 (1-2), 196-203, 2011
1782011
Key findings towards optimising adalimumab treatment: the concentration–effect curve
MF Pouw, CL Krieckaert, MT Nurmohamed, D van der Kleij, L Aarden, ...
Annals of the rheumatic diseases 74 (3), 513-518, 2015
1772015
The emerging importance of IgG Fab glycosylation in immunity
FS van de Bovenkamp, L Hafkenscheid, T Rispens, Y Rombouts
The Journal of Immunology 196 (4), 1435-1441, 2016
1512016
Extensive glycosylation of ACPA-IgG variable domains modulates binding to citrullinated antigens in rheumatoid arthritis
Y Rombouts, A Willemze, JJBC van Beers, J Shi, PF Kerkman, ...
Annals of the rheumatic diseases 75 (3), 578-585, 2016
1442016
Pharmacokinetic features and presence of antidrug antibodies associate with response to infliximab induction therapy in patients with moderate to severe ulcerative colitis
JF Brandse, RA Mathôt, D van der Kleij, T Rispens, Y Ashruf, JM Jansen, ...
Clinical Gastroenterology and Hepatology 14 (2), 251-258. e2, 2016
1432016
A prominent lack of IgG1-Fc fucosylation of platelet alloantibodies in pregnancy
R Kapur, I Kustiawan, A Vestrheim, CAM Koeleman, R Visser, ...
Blood 123 (4), 471-480, 2014
1372014
Decoding the human immunoglobulin G-glycan repertoire reveals a spectrum of Fc-receptor-and complement-mediated-effector activities
G Dekkers, L Treffers, R Plomp, AEH Bentlage, M De Boer, ...
Frontiers in immunology 8, 877, 2017
1312017
Mechanism of immunoglobulin G4 Fab-arm exchange
T Rispens, P Ooijevaar-de Heer, O Bende, RC Aalberse
Journal of the American Chemical Society 133 (26), 10302-10311, 2011
1272011
Enrichment of sialylated IgG by lectin fractionation does not enhance the efficacy of immunoglobulin G in a murine model of immune thrombocytopenia
T Guhr, J Bloem, NIL Derksen, M Wuhrer, AHL Koenderman, RC Aalberse, ...
PloS one 6 (6), e21246, 2011
1242011
Human IgG4 binds to IgG4 and conformationally altered IgG1 via Fc-Fc interactions
T Rispens, P Ooievaar-De Heer, E Vermeulen, J Schuurman, ...
The Journal of Immunology 182 (7), 4275-4281, 2009
1202009
Clinical relevance of serum natalizumab concentration and anti-natalizumab antibodies in multiple sclerosis
A Vennegoor, T Rispens, EMM Strijbis, A Seewann, BMJ Uitdehaag, ...
Multiple Sclerosis Journal 19 (5), 593-600, 2013
1192013
Fc gamma receptor-TLR cross-talk elicits pro-inflammatory cytokine production by human M2 macrophages
LTC Vogelpoel, IS Hansen, T Rispens, FJM Muller, TMM Van Capel, ...
Nature communications 5 (1), 1-8, 2014
1172014
The antibody response against human and chimeric anti-TNF therapeutic antibodies primarily targets the TNF binding region
KA van Schie, MH Hart, ER de Groot, S Kruithof, LA Aarden, GJ Wolbink, ...
Annals of the rheumatic diseases 74 (1), 311-314, 2015
1112015
Species-specific determinants in the IgG CH3 domain enable Fab-arm exchange by affecting the noncovalent CH3–CH3 interaction strength
AF Labrijn, T Rispens, J Meesters, RJ Rose, TH den Bleker, S Loverix, ...
The Journal of Immunology 187 (6), 3238-3246, 2011
1102011
The system can't perform the operation now. Try again later.
Articles 1–20